Far-Infrared Therapy Improves Arteriovenous Fistula Patency and Decreases Plasma Asymmetric Dimethylarginine in Patients with Advanced Diabetic Kidney Disease: A Prospective Randomized Controlled Trial

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase and plays a significant role in the pathogenesis of arteriovenous fistula (AVF) dysfunction. The aim of this study is to evaluate the effect of far-infrared (FIR) therapy on the maturation and patency of newly-cre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-Fan, Lee, Chiu-Yang, Chen, Fu-An, Yang, Chih-Yu, Chen, Tz-Heng, Ou, Shuo-Ming, Lee, Kuo-Hua, Li, Ching-Po, Chan, Chia-Hao, Lee, Pui-Ching, Chen, Yung-Tai, Lee, Tsung-Lun, Ho, Yang, Chen, Fan-Yu, Ma, Hao-Wei, Chen, Jinn-Yang, Tan, Ann Charis, Li, Szu-Yuan, Lin, Chih-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325296/
https://www.ncbi.nlm.nih.gov/pubmed/35887935
http://dx.doi.org/10.3390/jcm11144168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325296/
https://www.ncbi.nlm.nih.gov/pubmed/35887935
http://dx.doi.org/10.3390/jcm11144168

Ejemplares similares